Gilles FREYER
Hospices Civils de Lyon · HCL - Centre Hospitalier Lyon Sud · Centre Hospitalier Lyon Sud
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gilles FREYER as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:37 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07859319 · Evaluation of the Efficacy and Acceptability of a Phytotherapy Combining Devil's Claw, Blackcurrant and Meadowsweet for the Management of Aromatase Inhibitor-induced Arthralgia in Patients Treated for Localized Breast Cancer in the Adjuvant SettingHospices Civils de Lyon · not yet recruiting · Hormone Therapy-induced Arthralgia, Phytotherapy, Symptom Management · principal investigator
- Ph2NCT05183984 · Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian CancerARCAGY/ GINECO GROUP · recruiting · Ovarian Cancer · principal investigator
- Ph3NCT04158362 · Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast CancerUNICANCER · active not recruiting · Cancer Metastatic · principal investigator
- Ph2NCT04015739 · Tri Association in Patient With Advanced Epithelial Ovarian Cancer in RelapseARCAGY/ GINECO GROUP · unknown · Epithelial Ovarian Cancer, Relapse · principal investigator
- Ph1/Ph2NCT03959761 · Tolerance of Intraperitoneal (IP) Nivolumab After Extensive Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Ovarian CarcinomaHospices Civils de Lyon · completed · Ovarian Cancer · principal investigator
- Ph1NCT02392845 · A Pilot Dose Escalation Trial of a Densified Chemotherapy Association of Docetaxel and Epirubicin Driven by Mathematical Modeling in Metastatic Breast Cancer Patients: The MODEL1 StudyHospices Civils de Lyon · completed · Metastatic Breast Cancer · principal investigator
- Ph1/Ph2NCT01705158 · Myocet ® - Carboplatine in Ovarian Cancer in Relapse, Sensitive to the PlatinumARCAGY/ GINECO GROUP · completed · Ovarian Cancer · principal investigator
- Ph3NCT00525096 · Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast CancerARCAGY/ GINECO GROUP · completed · Metastatic Breast Cancer · principal investigator
- Ph2NCT00231075 · Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III-IVARCAGY/ GINECO GROUP · completed · Ovarian Cancer · principal investigator
- Ph4NCT00138060 · Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic DeterminantsInstitut de Recherche Clinique sur les Cancers et le Sang · completed · Metastatic Colorectal Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 09:37 UTC. The ranking covers the 200 most relevant of 57 PubMed records, and a shared surname and initials can bring in a namesake. All 57 on PubMed
- Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.J Clin Oncol · 20003,156 citationsRCR 74.5
- Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.N Engl J Med · 20191,854 citationsRCR 69.4
- 566 citationsRCR 14.1
- Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study.J Clin Oncol · 2003187 citationsRCR 5.5
- Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapy.J Clin Oncol · 2003184 citationsRCR 3.6
- Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer.Arch Surg · 2004182 citationsRCR 5.7
- 162 citationsRCR 18.5
- Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial.J Clin Oncol · 2003161 citationsRCR 3.9
- CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial.Clin Cancer Res · 2020118 citationsRCR 5.4
- 106 citationsRCR 8.2